Clinical Trial Update: RETRO (REduction of Therapy in RA Patients in Ongoing Remission) [Phase 3]

View source ↗

Summary

A Phase 3 trial named RETRO investigates reducing therapy in rheumatoid arthritis patients who are in ongoing remission. The study status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Rheumatoid Arthritis | Phase 3 | Status: UNKNOWN